Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) is a biopharmaceutical company. Questcor primary product is H.P. Acthar Gel (repository corticotropin injection) (Acthar), an injectable drug that is approved by the United States Food and Drug Administration (FDA).

Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) is a biopharmaceutical company. Questcor primary product is H.P. Acthar Gel (repository corticotropin injection) (Acthar), an injectable drug that is approved by the United States Food and Drug Administration (FDA).

Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) achieved its new 52 week high price of $45.95 where it was opened at $43.17 up 3.08 points or +7.25% by closing at $45.59. QCOR transacted shares during the day were over 2.89 million shares however it has an average volume of 1.07 million shares.

Read Full Article and Disclaimer at: http://crwewallstreetnewsalert.com/?p=6823

Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) achieved its new 52 week high price of $44.51 where it was opened at $42.97 up 1.01 points or +2.33% by closing at $44.36. QCOR transacted shares during the day were over 1.08 million shares however it has an average volume of 1.16 million shares.

Read Full Article and Disclaimer at: http://crwewallstreetnewsalert.com/?p=6460